Coya Therapeutics Analyst Ratings
Coya Therapeutics Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/09/2023 | 182.05% | Chardan Capital | → $11 | Reiterates | Buy → Buy |
| 07/18/2023 | 182.05% | Chardan Capital | → $11 | Reiterates | Buy → Buy |
| 07/18/2023 | 617.95% | EF Hutton | → $28 | Reiterates | Buy → Buy |
| 07/17/2023 | 182.05% | Chardan Capital | $11 → $11 | Reiterates | Buy → Buy |
| 06/08/2023 | 182.05% | Chardan Capital | $9 → $11 | Maintains | Buy |
| 06/07/2023 | 617.95% | EF Hutton | → $28 | Reiterates | Buy → Buy |
| 05/18/2023 | 284.62% | BTIG | → $15 | Initiates Coverage On | → Buy |
| 05/17/2023 | 130.77% | Chardan Capital | → $9 | Reiterates | Buy → Buy |
| 05/16/2023 | 617.95% | EF Hutton | → $28 | Reiterates | Buy → Buy |
| 05/10/2023 | 617.95% | EF Hutton | → $28 | Reiterates | Buy → Buy |
| 05/03/2023 | 617.95% | EF Hutton | → $28 | Initiates Coverage On | → Buy |
| 03/30/2023 | 130.77% | Chardan Capital | → $9 | Reiterates | → Buy |
| 03/22/2023 | 130.77% | Chardan Capital | → $9 | Reiterates | → Buy |
| 01/26/2023 | 130.77% | Chardan Capital | → $9 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 08/09/2023 | 182.05% | 查尔丹资本 | →$11 | 重申 | 购买→购买 |
| 07/18/2023 | 182.05% | 查尔丹资本 | →$11 | 重申 | 购买→购买 |
| 07/18/2023 | 617.95% | EF Hutton | →$28 | 重申 | 购买→购买 |
| 07/17/2023 | 182.05% | 查尔丹资本 | $11→$11 | 重申 | 购买→购买 |
| 06/08/2023 | 182.05% | 查尔丹资本 | $9→$11 | 维护 | 买 |
| 06/07/2023 | 617.95% | EF Hutton | →$28 | 重申 | 购买→购买 |
| 2023年05月18日 | 284.62% | BTIG | →$15 | 开始承保 | →购买 |
| 2023年05月17日 | 130.77% | 查尔丹资本 | →$9 | 重申 | 购买→购买 |
| 2023年05月16日 | 617.95% | EF Hutton | →$28 | 重申 | 购买→购买 |
| 2023年05月10日 | 617.95% | EF Hutton | →$28 | 重申 | 购买→购买 |
| 05/03/2023 | 617.95% | EF Hutton | →$28 | 开始承保 | →购买 |
| 03/30/2023 | 130.77% | 查尔丹资本 | →$9 | 重申 | →购买 |
| 03/22/2023 | 130.77% | 查尔丹资本 | →$9 | 重申 | →购买 |
| 2023年1月26日 | 130.77% | 查尔丹资本 | →$9 | 开始承保 | →购买 |
What is the target price for Coya Therapeutics (COYA)?
Coya治疗公司(Coya)的目标价格是多少？
The latest price target for Coya Therapeutics (NASDAQ: COYA) was reported by Chardan Capital on August 9, 2023. The analyst firm set a price target for $11.00 expecting COYA to rise to within 12 months (a possible 182.05% upside). 14 analyst firms have reported ratings in the last year.
查尔丹资本于2023年8月9日报道了Coya治疗公司(纳斯达克：COYA)的最新目标价。这家分析公司将目标价定为11美元，预计Coya将在12个月内上涨至(可能上涨182.05%)。过去一年，有14家分析公司公布了评级。
What is the most recent analyst rating for Coya Therapeutics (COYA)?
Coya治疗公司(Coya)的最新分析师评级是多少？
The latest analyst rating for Coya Therapeutics (NASDAQ: COYA) was provided by Chardan Capital, and Coya Therapeutics reiterated their buy rating.
科亚治疗公司(纳斯达克代码：COYA)的最新分析师评级由查尔丹资本提供，科亚治疗公司重申其买入评级。
When is the next analyst rating going to be posted or updated for Coya Therapeutics (COYA)?
Coya治疗公司(Coya)的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Coya Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Coya Therapeutics was filed on August 9, 2023 so you should expect the next rating to be made available sometime around August 9, 2024.
分析师在进行了广泛的研究后得出股票评级，其中包括查阅公共财务报表，与科亚治疗公司的高管和客户交谈，以及听取收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。Coya治疗公司的上一次评级是在2023年8月9日提交的，所以你应该预计下一次评级将在2024年8月9日左右提供。
Is the Analyst Rating Coya Therapeutics (COYA) correct?
分析师对Coya Treateutics(Coya)的评级正确吗？
While ratings are subjective and will change, the latest Coya Therapeutics (COYA) rating was a reiterated with a price target of $0.00 to $11.00. The current price Coya Therapeutics (COYA) is trading at is $3.90, which is within the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的Coya治疗公司(Coya)评级被重申，目标价在0.00美元至11.00美元之间。Coya治疗公司(Coya)目前的交易价格为3.90美元，在分析师的预测范围内。